5-FU	5-fluorouracil
5′ND	5-nucleotidase
6CEPN	6-C-(E-phenylethyl)-naringenin
ACF	aberrant crypt foci
AOM	azoxymethane
APC	adenomatous polyposis coli
ATST	atorvastatin
BAX	B-cell lymphoma 2-associated x protein
BCL-2	B-cell lymphoma 2
BID	BH3 interacting-domain death agonist
BRAF-B	rapidly accelerated fibrosarcoma/murine sarcoma viral oncogene homolog B
CAC	colitis-associated colorectal cancer
CACNA14	voltage-dependent P/Q type calcium channel subunit alpha1A
CAP	capecitabine
CAPE,	caffeic acid phenethyl ester
CAPPE	caffeic acid phenylpropyl ester
CAPE-pNO2	caffeic acid p-nitro-phenylethyl ester
CAPIRI	capecitabine and irinotecan
CAPOX	capecitabine and oxaliplatin
CEA	carcinoembryonic antigen
CIMP	CpG island methylation phenotype
CIN	chromosomal instability
CLXC12	C–X–C chemokine 12
COX-2	cyclooxygenase-2
CRC	colorectal cancer
CSC	cancer stem cell
cyt. c	cytochrome c
DII	dietary inflammatory index
Dkk	Dickkopf
DMH	dimethyl hydrazine
DNMT	DNA methyltransferase
DSS	dextran sulphate sodium
Dvl	Discevelled
EGF-β	epidermal growth factor-β
EGFR	epidermal growth factor receptor
ER	endoplasmic reticulum
ERK	extracellular signal-regulated kinase
FAP	familial adenomatous polyposis syndrome
FDA	Federal Drug Administration
FOLFOX	5-FU and oxaliplatin
FOXFIRI	5-FU and irinotecan
FZD	Frizzled receptor
G6PD	glucose-6-phosphate dehydrogenase
GEPIA	gene expression profiling interactive analysis
GGT	γ-glutamyl transferase
GSH	glutathione
GSK-3β	glycogen synthase kinase-3β
GTP	green tea polyphenol
HMACF	high multiplicity aberrant crypt foci
hMLH1	human MutL homolog 1
HPP	hyperplastic polyposis
IDEA	International Duration Evaluation of Adjuvant Chemotherapy
IGF-2	insulin like growth factor-2
IGFBP3	insulin like growth factor-binding protein 3
iNOS	inducible nitric oxide synthase
IRI	irinotecan
KRAS	Kirsten rat sarcoma viral oncogene homolog
LC3B	light chain 3B of microtubule-associated proteins 1A/1B
LPO	lipid peroxide
MAP	MUTYG- associated polyposis
MAPK	mitogen-activated protein kinase
MMP	matrix metalloproteinase
MSI	microsatellite instability
mTOR	mammalian target of rapamycin
NF-κβ	nuclear factor-κβ
NO	nitric oxide
NSAID	nonsteroidal anti-inflammatory drug
oncomiRs	oncogenic miRNAs
OPE	orange peel extract
OX	oxaliplatin
PDTX	patient-derived tumor xenograft
PI3K	phosphoinositide 3-kinase
PPE	polyphenol E
PTEN	phosphatase and tensin homolog deleted on chromosome 10
SEER	surveillance epidemiology and end results
SGK1	serum glucocorticoid kinase 1
Skip	Ski-interacting protein
SOD	superoxide dismutase
SPI	soya protein isolate
TAGE	tangeretin
TIMP	tissue inhibitor metalloproteinase
TNM	tumor/node/metastasis
TRPV1	transient receptor potential vanilloid 1
VEGF	vascular endothelial growth factor
VEGFR	vascular endothelial growth factor receptor
YAP	yes-associated protein
yCRC	young-onset colorectal cancer